It stabilizes delicate mitochondrial membranes, significantly reduces the generation of destructive reactive oxygen species (ROS), and protects the cell from ferroptosis, a severe form of iron-dependent cell death
The Phase III BLISS-LN study demonstrated that belimumab, a BAFF monoclonal antibody, significantly outperforms placebo in treating LN, effectively reducing organ damage while maintaining good tolerability (Furie et al
Three SAM molecules are required for the methylation of phosphatidylethanolamine to phosphatidylcholine by phosphatidylethanolamine N-methyltransferase (PEMT)
XW: Formal Analysis, Project administration, Writing review & editing
doi:10.1016/j.neuint.2012.04.008 [72] Benvenga S, Feldt-Rasmussen U, Bonofiglio D, et al
Even high-profile leaders sometimes promote unsafe products, and many of us have lost confidence in government health websites like the CDC, which were once considered reliable sources